Jeffrey S. Mumm, Ph.D., an associate professor of ophthalmology, Wilmer Eye Institute, has received a National Institutes of Health grant to develop a phenotypic screening platform for large-scale drug discovery. The platform will be the centerpiece of a new Johns Hopkins CORE facility enabling large-scale drug discovery to be performed in living disease models.